These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 17086867

  • 1. Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH).
    Sasaki N, Ueno T, Morita Y, Nagata E, Sata M.
    Hepatogastroenterology; 2006; 53(71):678-81. PubMed ID: 17086867
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.
    Shimada M, Kawahara H, Ozaki K, Fukura M, Yano H, Tsuchishima M, Tsutsumi M, Takase S.
    Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis.
    Lesmana CR, Hasan I, Budihusodo U, Gani RA, Krisnuhoni E, Akbar N, Lesmana LA.
    J Dig Dis; 2009 Aug; 10(3):201-6. PubMed ID: 19659788
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L, Forgione A, La Torre G, Vero V, Cefalo C, Racco S, Vellone VG, Vecchio FM, Gasbarrini G, Rapaccini GL, Neuman MG, Grieco A.
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [Abstract] [Full Text] [Related]

  • 5. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
    Tsukamoto T, Yamamoto T, Ikebe T, Takemura S, Shuto T, Kubo S, Hirohashi K, Kinoshita H.
    Hepatogastroenterology; 2004 Oct; 51(57):777-80. PubMed ID: 15143915
    [Abstract] [Full Text] [Related]

  • 6. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
    Palekar NA, Naus R, Larson SP, Ward J, Harrison SA.
    Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
    [Abstract] [Full Text] [Related]

  • 7. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S, Yukawa T, Uetake S, Yamauchi M.
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [Abstract] [Full Text] [Related]

  • 8. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS, Weiss DG, Paronetto F, Veterans Affairs Cooperative Study 391 Group.
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [Abstract] [Full Text] [Related]

  • 9. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
    Tanwar S, Trembling PM, Guha IN, Parkes J, Kaye P, Burt AD, Ryder SD, Aithal GP, Day CP, Rosenberg WM.
    Hepatology; 2013 Jan; 57(1):103-11. PubMed ID: 22930399
    [Abstract] [Full Text] [Related]

  • 10. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.
    Lydatakis H, Hager IP, Kostadelou E, Mpousmpoulas S, Pappas S, Diamantis I.
    Liver Int; 2006 Sep; 26(7):864-71. PubMed ID: 16911470
    [Abstract] [Full Text] [Related]

  • 11. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
    Bahcecioglu IH, Yalniz M, Ataseven H, Ilhan N, Ozercan IH, Seckin D, Sahin K.
    Hepatogastroenterology; 2005 Sep; 52(65):1549-53. PubMed ID: 16201116
    [Abstract] [Full Text] [Related]

  • 12. Serum leptin levels in patients with nonalcoholic steatohepatitis.
    Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci MS, Bagci S, Gulsen M, Karaeren N, Dagalp K.
    Am J Gastroenterol; 2000 Dec; 95(12):3584-9. PubMed ID: 11151896
    [Abstract] [Full Text] [Related]

  • 13. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A, Deulofeu R, Giménez A, Caballería L, Bruguera M, Caballería J, Ballesta AM, Rodés J.
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [Abstract] [Full Text] [Related]

  • 14. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
    Xie SB, Yao JL, Zheng SS, Yao CL, Zheng RQ.
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
    [Abstract] [Full Text] [Related]

  • 15. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
    Xie SB, Yao JL, Zheng RQ, Peng XM, Gao ZL.
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
    [Abstract] [Full Text] [Related]

  • 16. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP, Feng XR, Dai L, Ding HB, Zhang L.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [Abstract] [Full Text] [Related]

  • 17. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M, Rautiainen H, Kärkkäinen P, Karvonen AL, Nurmi H, Niemelä O.
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [Abstract] [Full Text] [Related]

  • 18. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD, Maddox AJ, Green CA, Tatnall F, Schofield JK, Stott DJ.
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [Abstract] [Full Text] [Related]

  • 19. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 20. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M.
    Acta Biochim Pol; 2011 Dec; 58(4):563-6. PubMed ID: 22140659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.